Healthcare

Pathology services are essential for healthcare systems, as doctors rely on laboratory tests to diagnose medical conditions and monitor treatment effectiveness.

CSL Behring focuses on plasma therapies used to treat rare and serious diseases, while CSL Seqirus is a leading global influenza vaccine provider. CSL Vifor specializes in treatments for iron deficiency and kidney disease.

Mesoblast operates with dual listings on theASX (MSB)andNASDAQ (MESO), providing international investor access to its regenerative medicine pipeline. The company also maintains a financial position that includesapproximately $130M in cash reserves, supporting ongoing commercialization and clinical development activities.

Telix Pharmaceuticals (ASX:TLX) delivered one of the most striking moves on the Australian Securities Exchange on March 10, 2026. The move reflects growing investor conviction in the Melbourne-based radiopharmaceutical company's transition from a clinical-stage firm to a profitable, globally significant commercial enterprise.

Key Market DataMetricValueContextCurrent Price$180.17Change: +011Daily Change+0.061%GainingMarket Capitalisation$11.7BHealthcare sector1-Year Return-33.02%Underperforming1. Company OverviewCochlear Limited (ASX:COH) is the global leader in implantable hearing solutions. Based in Sydney, the company designs, manufactures, and supplies cochlear implant systems, bone conduction hearing devices, and acoustic implants to people with moderate …

Ramsay Health Care, founded in 1964 and headquartered in Sydney, operates over 650 healthcare sites across 11 countries, making it a truly global healthcare enterprise. The company is the largest private hospital operator in Australia, France, and Sweden, and holds a significant market position …

The sell-off reflects investor reassessment of AI commercialization timing and clinical adoption rates, after management commentary suggested timing pressures onrevenuerealization. Artrya has demonstrated strong technical capabilities with the Salix platform and has secured a significant five-year SaaS deal with Cone Health, positioning the company …